Healthcare news from The Accelerated Cure Project
The majority of people with MS have other diseases to manage. These other illnesses, called comorbidities, have been shown to impact MS diagnosis, treatment and disease course. In case you missed it, our July newsletterfocuses on the potential impact of comorbidities on people with MS. Our first article sheds light on which other health conditions are most common in people with MS and how they may affect those living with the disease.
It’s important for people with MS to assemble a healthcare team with the appropriate specialists to manage the many facets of MS and any comorbidities they may have. Learn more about managing MS and other maladies and some simple strategies to help people with MS achieve the best outcomes and quality of life possible.
The majority of people with MS have other diseases to manage. These other illnesses, called comorbidities, have been shown to impact MS diagnosis, treatment and disease course. In case you missed it, our July newsletterfocuses on the potential impact of comorbidities on people with MS. Our first article sheds light on which other health conditions are most common in people with MS and how they may affect those living with the disease.
It’s important for people with MS to assemble a healthcare team with the appropriate specialists to manage the many facets of MS and any comorbidities they may have. Learn more about managing MS and other maladies and some simple strategies to help people with MS achieve the best outcomes and quality of life possible.
.........................................................................................................
CLICK Red BOX to SUBSCRIBE to our MS Learning Channel
Click Red Box on banner to opt-in
........................................................................................................
This Article is Provided by: #MSViewsandNews
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
0 Comments: